Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QMID (Quantitative Medical Imaging and Diagnostics) is an Italian health-tech company specializing in AI-driven medical imaging solutions. The company's primary focus is on the non-invasive quantification of liver fat and iron through MRI analysis, providing clinicians with precise diagnostic tools for metabolic diseases such as NAFLD and NASH. Their flagship platform, also named Q-MID, utilizes advanced algorithms to automate the processing of MRI scans, reducing the need for invasive biopsies. QMID operates as a spin-off from the University of Verona and aims to standardize quantitative imaging in clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QMID.